# FDA recall D-0763-2022

> **Adamis Pharmaceuticals Corporation** · Class I · drug recall initiated 2022-03-21.

## Product

SYMJEPI (epinephrine injection, USP) 0.3 mg, (0.3 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Adamis Pharmaceuticals Corp.; San Diego, CA  92130; Distributed by USWM, LLC., Louisville, KY  40241, Made in Belgium, NDC 78670-130-02

## Reason for recall

Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.

## Distribution

Nationwide in the U.S.A.

## Key facts

- **Recall number:** D-0763-2022
- **Recalling firm:** Adamis Pharmaceuticals Corporation
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-03-21
- **Report date:** 2022-04-13
- **Termination date:** 2023-02-08

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** San Diego, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0763-2022

## Citation

> AI Analytics. FDA recall D-0763-2022. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0763-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*